She was initially on continuous insulin pump therapy (MinimedTM 640G) along with a Continuous Glucose Monitoring (CGM) system with Predictive Low Glucose Suspend (PLGS) technology, that allows the suspension of insulin delivery when hypoglycemia is predicted by the algorithm. The gene discussed is INS; the disease is Hypoglycemia.